Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
Status:
RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to determine how two different doses of cannabidiol (CBD), given as a hemp product, change the blood concentrations of the drug clopidogrel in the body. Results will be used to help design future studies and to assist healthcare providers in informing their patients about the safe use of CBD.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Washington State University
Collaborators:
National Center for Complementary and Integrative Health (NCCIH) Office of Dietary Supplements (ODS)